Literature DB >> 21596293

Long-term outcome of primary congenital glaucoma.

Don Julian de Silva1, Peng T Khaw, John L Brookes.   

Abstract

PURPOSE: To evaluate the long-term outcome of primary congenital glaucoma in patients followed for more than 20 years.
METHODS: All patients with a diagnosis of congenital glaucoma who were examined in the pediatric glaucoma clinic at Moorfields Eye Hospital from 2005 to 2006 were included. The follow-up period was a minimum of 20 years; patients with pediatric glaucoma secondary to other etiologies were excluded. Data collected included visual acuity, optic disk cupping, intraocular pressure (IOP), corneal diameter, pachymetry, visual fields, refraction, strabismus, glaucoma management, and ocular comorbidity. Progressive congenital glaucoma, defined as an increase of the cup/disk ratio of >0.2 secondary to elevated IOP, was evaluated with the use of Kaplan-Meier survival curves. Patients were divided into 1 of 3 groups: (1) stable glaucoma with no visual impairment; (2) glaucoma progression with sight-threatening consequences; and (3) poor visual acuity as a result of ocular comorbidity.
RESULTS: A total of 30 eyes of 16 patients were identified. Mean follow-up was 34 ± 10 years (range, 22-59 years). At the final clinical assessment, mean IOP was 13.6 ± 4.3 mm Hg and mean cup/disk ratio was 0.7 ± 0.3 (p < 0.05). Survival analysis demonstrated lack of progression in 90.3% at 1 year, 83.1% at 5 years, 70.8% at 10 years, 58.3% at 34 years, and 48.6% at 40 years.
CONCLUSIONS: Apparently stable congenital glaucoma may progress with sight-threatening complications after many years of IOP stability. Monitoring of these patients is indicated throughout life.
Copyright © 2011 American Association for Pediatric Ophthalmology and Strabismus. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21596293     DOI: 10.1016/j.jaapos.2010.11.025

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  9 in total

Review 1.  Eye pathologies in neonates.

Authors:  Nyaish Mansoor; Tihami Mansoor; Mansoor Ahmed
Journal:  Int J Ophthalmol       Date:  2016-12-18       Impact factor: 1.779

2.  Corneal white-to-white distance and mesopic pupil diameter.

Authors:  Hasan Basri Cakmak; Nurullah Cagil; Huseyin Simavli; Sabri Raza
Journal:  Int J Ophthalmol       Date:  2012-08-18       Impact factor: 1.779

3.  Genetic analysis of patients with primary congenital glaucoma.

Authors:  Sedat Ava; Atılım Armağan Demirtaş; Mine Karahan; Seyfettin Erdem; Diclehan Oral; Uğur Keklikçi
Journal:  Int Ophthalmol       Date:  2021-03-21       Impact factor: 2.031

4.  Caregiver Burden in Primary Congenital Glaucoma.

Authors:  Aditi Kantipuly; Manju R Pillai; Sujani Shroff; Rakhee Khatiwala; Ganesh V Raman; S R Krishnadas; Alan Lee Robin; Joshua R Ehrlich
Journal:  Am J Ophthalmol       Date:  2019-05-10       Impact factor: 5.258

5.  Long-term structural and functional outcomes of primary congenital glaucoma.

Authors:  Yun Hsia; Tso-Ting Lai; Chien-Chia Su; Tsing-Hong Wang; Jehn-Yu Huang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-04-22       Impact factor: 3.117

6.  Therapeutic effect analysis on the treatment of congenital glaucoma through modified combined trabeculotomy-trabeculectomy.

Authors:  Zhen-Kai Wu; Jing Wu; Qian Tan; Jian Jiang; Wei-Tao Song; Xiao-Bo Xia
Journal:  Int J Ophthalmol       Date:  2016-02-18       Impact factor: 1.779

7.  Characteristics of Pediatric Glaucoma in a Latin American Reference Center.

Authors:  Catalina Saavedra; Hernan A Rios; Sandra Belalcazar; Shirley M Rosenstiehl
Journal:  J Curr Glaucoma Pract       Date:  2020 Jan-Apr

Review 8.  Pediatric Glaucoma: A Literature's Review and Analysis of Surgical Results.

Authors:  Gianluca Scuderi; Daniela Iacovello; Federica Pranno; Pasquale Plateroti; Luca Scuderi
Journal:  Biomed Res Int       Date:  2015-09-16       Impact factor: 3.411

9.  Primary congenital glaucoma surgery: outcomes and visual function.

Authors:  Elena Gusson; Francesca Chemello; Rosa Longo; Elia Franzolin; Roberta Vesentini; Giuseppe Verlato; Giorgio Marchini
Journal:  Int Ophthalmol       Date:  2021-07-23       Impact factor: 2.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.